AMPH
Price
$25.71
Change
+$0.07 (+0.27%)
Updated
May 30 closing price
Capitalization
2.11B
72 days until earnings call
PAHC
Price
$24.42
Change
-$0.24 (-0.97%)
Updated
May 30 closing price
Capitalization
523.71M
88 days until earnings call
Interact to see
Advertisement

AMPH vs PAHC

Header iconAMPH vs PAHC Comparison
Open Charts AMPH vs PAHCBanner chart's image
Amphastar Pharmaceuticals
Price$25.71
Change+$0.07 (+0.27%)
Volume$460.92K
Capitalization2.11B
Phibro Animal Health
Price$24.42
Change-$0.24 (-0.97%)
Volume$267.86K
Capitalization523.71M
AMPH vs PAHC Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. PAHC commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (AMPH: $25.73 vs. PAHC: $24.41)
Brand notoriety: AMPH and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 78% vs. PAHC: 109%
Market capitalization -- AMPH: $2.11B vs. PAHC: $523.71M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while PAHC’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 3 bearish.
  • PAHC’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both AMPH and PAHC are a good buy in the short-term.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +5.15% price change this week, while PAHC (@Pharmaceuticals: Other) price change was +5.03% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.93%. For the same industry, the average monthly price growth was +18.62%, and the average quarterly price growth was +73.57%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than AMPH: PAHC (34.11) vs AMPH (16.69). PAHC YTD gains are higher at: 16.820 vs. AMPH (-30.703). AMPH has higher annual earnings (EBITDA): 240M vs. PAHC (83.7M). AMPH has more cash in the bank: 257M vs. PAHC (92.5M). PAHC has less debt than AMPH: PAHC (513M) vs AMPH (624M). PAHC has higher revenues than AMPH: PAHC (982M) vs AMPH (644M).
AMPHPAHCAMPH / PAHC
Capitalization2.11B524M403%
EBITDA240M83.7M287%
Gain YTD-30.70316.820-183%
P/E Ratio16.6934.1149%
Revenue644M982M66%
Total Cash257M92.5M278%
Total Debt624M513M122%
FUNDAMENTALS RATINGS
AMPH vs PAHC: Fundamental Ratings
AMPH
PAHC
OUTLOOK RATING
1..100
1523
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
7984
SMR RATING
1..100
4561
PRICE GROWTH RATING
1..100
6440
P/E GROWTH RATING
1..100
8991
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (23) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMPH (63) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (79) in the Pharmaceuticals Other industry is in the same range as PAHC (84) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to PAHC’s over the last 12 months.

AMPH's SMR Rating (45) in the Pharmaceuticals Other industry is in the same range as PAHC (61) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (40) in the Pharmaceuticals Major industry is in the same range as AMPH (64) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (89) in the Pharmaceuticals Other industry is in the same range as PAHC (91) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHPAHC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 18 days ago
70%
Bearish Trend 10 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CTOGX14.750.03
+0.20%
Calamos Timpani SMID Growth R6
AGGRX10.74N/A
N/A
American Century Focused Global Gr A
NPNCX46.23N/A
N/A
Neuberger Berman Large Cap Value C
RMBNX40.52N/A
N/A
RMB Mendon Financial Services C
RYOCX83.51N/A
N/A
Rydex NASDAQ-100® Inv

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.35%
AMRX - AMPH
35%
Loosely correlated
+0.14%
ALKS - AMPH
32%
Poorly correlated
+1.19%
COLL - AMPH
31%
Poorly correlated
-0.21%
PAHC - AMPH
29%
Poorly correlated
-1.01%
VTRS - AMPH
29%
Poorly correlated
-0.57%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-1.01%
PBH - PAHC
49%
Loosely correlated
+1.41%
AMRX - PAHC
44%
Loosely correlated
+0.14%
ZTS - PAHC
40%
Loosely correlated
+0.89%
VTRS - PAHC
38%
Loosely correlated
-0.57%
ELAN - PAHC
34%
Loosely correlated
-0.59%
More